Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Generic Claims:
advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes…
Red Flags:
FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified…
Semantic Drift Patterns:
homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations:
specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations…
ENBREL (Amgen)
(https://enbrel.com) 📸 Data Snapshot: May 30, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE ENBREL® (etanercept) | Official Patient Site (https://enbrel.com)
Title
ENBREL® (etanercept) | Official Patient Site
Meta
Learn about Enbrel® (etanercept), a treatment option for autoimmune diseases like moderate to severe rheumatoid arthritis and psoriatic arthritis. See Full Prescribing & Safety Info.
H1 THINKING ABOUT ENBREL?
H2 ENBREL is approved to treat the following conditions:
H3 You are about to go to the ENBREL website for healthcare professionals.
H3 ENBREL is approved to treat the following conditions:
H3 Pay as little as $0*
H3 INDICATIONS
H6 Indications
NAV_HEADER_HEADING_REPEATED_BODY Financial Support and Patient Resources | ENBREL® (etanercept) (https://enbrel.com/support/)
Title
Financial Support and Patient Resources | ENBREL® (etanercept)
Meta
Find financial support options, support services, and patient resources. See Full Prescribing & Safety Info.
H1 Already have a prescription? Enroll in the ENBREL® Co-Pay Program*
H2 Add us to your contacts
H2 Add us to your contacts
H3 You are about to go to the ENBREL website for healthcare professionals.
H3 Patient Date of Birth
H3 Insurance Information
H3 COMMERCIAL INSURANCE
H3 GOVERNMENT-PROVIDED
H3 I DON'T HAVE INSURANCE
H3 Patient Information
H3 Healthcare Representative (complete, if applicable)
H3 SUMMARY OF TERMS AND CONDITIONS
H3 ENBREL® Co-Pay Card
H3 INDICATIONS
H4 Patient Authorization and Consents
H4 Additional Disclosures
H5 Are you eligible for Medicare but receive prescription drug coverage from a former employer, union, or welfare plan?
H5 Step 1 of 4
H5 Step 2 of 4
H5 Step 3 of 4
H5 Step 4 of 4
H6 Indications
H6 *Please make a selection
H6 *Please make a selection
H6 *Please make a selection
H6 *Please make a selection
NAV_HEADER_REPEATED Rheumatoid Arthritis Treatment | ENBREL® (etanercept) (https://enbrel.com/rheumatoid-arthritis/)
Title
Rheumatoid Arthritis Treatment | ENBREL® (etanercept)
Meta
Learn about ENBREL® (etanercept) for moderate to severe rheumatoid arthritis (RA). See Full Prescribing & Safety Info.
H1 Watch how joint damage may progress over time.*
H2 POSSIBLE SIDE EFFECTS
H2 #1 How is RA making you feel overall?
H2 #2 Any new or worsening symptoms?
H2 #3 How do your symptoms affect your daily activities?
H2 Get the Doctor Discussion Guide
H3 You are about to go to the ENBREL website for healthcare professionals.
H3 How can ENBREL help you with moderate to severe rheumatoid arthritis?
H3 How can ENBREL help you with moderate to severe rheumatoid arthritis?
H3 How long does it take for ENBREL to work for rheumatoid arthritis?
H3 Joint Damage Simulator
H3 3 topics to bring up with your healthcare provider
H3 INDICATIONS
H4 significantly relieve joint pain
H4 stop permanent joint damage
H5 WHY ENBREL?
How can ENBREL help you with moderate to severe rheumatoid arthritis?
H5 Whether you have moderate to severe rheumatoid arthritis (RA) or psoriatic arthritis (PsA), joint pain, stiffness, and swelling are common reminders of your condition. They can also be a sign of something else: permanent joint damage that cannot be undone.
Use the Joint Damage Simulator to see how permanent joint damage can progress if not treated with the right kinds of medication.
Watch how joint damage may progress over time.*
Rheumatoid Arthritis & Psoriatic ArthritisJoint Damage Simulator
CHOOSE YOUR CONDITION
Rheumatoid Arthritis (RA)
Psoriatic Arthritis (PSA)
SELECT JOINT
hand
foot
SHOULDER
KNEE
* This is not intended to be a diagnostic tool. Progression of joint damage is unique for each individual patient. Images are for demonstration purposes only. Talk to your doctor about your symptoms. This tool does not collect or store your personal information, but Amgen may collect Usage Data to help us improve, develop, evaluate, and continue products, services, materials, and programs related to our products and your condition. Please read the Amgen Privacy Statement for more details. USA-916-80151
Progression of joint damage is unique for each individual patient. Talk to your doctor about your symptoms. Images are for demonstration purposes only.
H6 Indications
NAV_HEADER_REPEATED Psoriatic Arthritis Treatment | ENBREL® (etanercept) (https://enbrel.com/psoriatic-arthritis/)
Title
Psoriatic Arthritis Treatment | ENBREL® (etanercept)
Meta
Find out more about psoriatic arthritis (PsA) and ENBREL® (etanercept). See Full Prescribing & Safety Info.
H1 Watch how joint damage may progress over time.*
H2 POSSIBLE SIDE EFFECTS
H2 #1 How is psoriatic arthritis making you feel overall?
H2 #2 Any new or worsening symptoms?
H2 #3 How do your symptoms affect your daily activities?
H2 Get the Doctor Discussion Guide
H3 You are about to go to the ENBREL website for healthcare professionals.
H3 How can ENBREL help you with adult psoriatic arthritis?
H3 How can ENBREL help you with adult psoriatic arthritis?
H3 How long does it take for ENBREL to work for adult psoriatic arthritis?
H3 Joint Damage Simulator
H3 3 topics to bring up with your healthcare provider
H3 INDICATIONS
H4 significantly relieve joint pain
H4 stop permanent joint damage
H5 WHY ENBREL?
How can ENBREL help you with adult psoriatic arthritis?
H5 Whether you have moderate to severe rheumatoid arthritis (RA) or psoriatic arthritis (PsA), joint pain, stiffness, and swelling are common reminders of your condition. They can also be a sign of something else: permanent joint damage that cannot be undone.
Use the Joint Damage Simulator to see how permanent joint damage can progress if not treated with the right kinds of medication.
Watch how joint damage may progress over time.*
Rheumatoid Arthritis & Psoriatic ArthritisJoint Damage Simulator
CHOOSE YOUR CONDITION
Rheumatoid Arthritis (RA)
Psoriatic Arthritis (PSA)
SELECT JOINT
hand
foot
SHOULDER
KNEE
* This is not intended to be a diagnostic tool. Progression of joint damage is unique for each individual patient. Images are for demonstration purposes only. Talk to your doctor about your symptoms. This tool does not collect or store your personal information, but Amgen may collect Usage Data to help us improve, develop, evaluate, and continue products, services, materials, and programs related to our products and your condition. Please read the Amgen Privacy Statement for more details. USA-916-80151
Progression of joint damage is unique for each individual patient. Talk to your doctor about your symptoms. Images are for demonstration purposes only.
H6 Indications
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://enbrel.com) ENBREL® (etanercept) | Official Patient Site
Close [H3] [H3] What is the most important information I should know about ENBREL? ENBREL is a medicine that affects your immune system. ENBREL can lower the ability of your immune system to fight infections. Serious infections have happened in patients taking ENBREL. These infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some patients have died from these infections. Your healthcare provider should test you for TB before you take ENBREL and monitor you closely for TB before, during, and after ENBREL treatment, even if you have tested negative for TB. There have been some cases of unusual cancers, some resulting in death, reported in children and teenagers who started using tumor necrosis factor (TNF) blockers before 18 years of age. Also, for children, teenagers, and adults taking TNF blockers, including ENBREL, the chances of getting lymphoma or other cancers may increase. Patients with RA may be more likely to get lymphoma. Before starting ENBREL, tell your healthcare provider if you: Have any existing medical conditions Are taking any medicines, including herbals Think you have, are being treated for, have signs of, or are prone to infection. You should not start taking ENBREL if you have any kind of infection, unless your healthcare provider says it is okay Have any open cuts or sores Have diabetes, HIV, or a weak immune system Have TB or have been in close contact with someone who has had TB Were born in, lived in, or traveled to countries where there is more risk for getting TB. Ask your healthcare provider if you are not sure Live, have lived in, or traveled to certain parts of the country (such as, the Ohio and Mississippi River valleys, or the Southwest) where there is a greater risk for certain kinds of fungal infections, such as histoplasmosis. These infections may develop or become more severe if you take ENBREL. If you don’t know if these infections are common in the areas you’ve been to, ask your healthcare provider Have or have had hepatitis B Have or have had heart failure Develop symptoms such as persistent fever, bruising, bleeding, or paleness while taking ENBREL Use the medicine Kineret (anakinra), Orencia (abatacept), or Cytoxan (cyclophosphamide) Are taking anti-diabetic medicines Have, have had, or develop a serious nervous disorder, seizures, any numbness or tingling, or a disease that affects your nervous system such as multiple sclerosis or Guillain-Barré syndrome Are scheduled to have surgery Have recently received or are scheduled for any vaccines. All vaccines should be brought up-to-date before starting ENBREL. Patients taking ENBREL should not receive live vaccines Are pregnant, planning to become pregnant, or breastfeeding Have been around someone with chicken pox What are the possible side effects of ENBREL? ENBREL can cause serious side effects including: New infections or worsening of infections you already have; hepatitis B can become active if you already have had it; nervous system problems, such as multiple sclerosis, seizures, or inflammation of the nerves of the eyes; blood problems (some fatal); new or worsening heart failure; new or worsening psoriasis; allergic reactions; autoimmune reactions, including a lupus-like syndrome and autoimmune hepatitis. Common side effects include: Injection site reactions and upper respiratory infections (sinus infections). In general, side effects in children were similar in frequency and type as those seen in adult patients. The types of infections reported were generally mild and similar to those usually seen in children. These are not all the side effects with ENBREL. Tell your healthcare provider about any side effect that bothers you or does not go away. If you have any questions about this information, be sure to discuss them with your healthcare provider. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Please see Prescribing Information and Medication Guide. [H3] INDICATIONS ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with moderately to severely active rheumatoid arthritis. ENBREL can be taken with methotrexate or used alone. ENBREL is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (pJIA) in children 2 years of age or older. ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in adult patients with psoriatic arthritis. ENBREL can be used with or without methotrexate. ENBREL is indicated for active juvenile psoriatic arthritis (JPsA) in children 2 years of age or older. ENBREL is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis. ENBREL is indicated for chronic moderate to severe plaque psoriasis (PsO) in children 4 years of age or older and adults who may benefit from taking injections or pills (systemic therapy) or phototherapy (ultraviolet light). Open [H5] What is the most important information I should know about ENBREL? ENBREL is a medicine that affects your immune system. ENBREL can lower the ability of your immune system to fight infections.
5484 chars
SUB-PAGE (https://enbrel.com/support/) Financial Support and Patient Resources | ENBREL® (etanercept)
Close [H3] [H3] What is the most important information I should know about ENBREL? ENBREL is a medicine that affects your immune system. ENBREL can lower the ability of your immune system to fight infections. Serious infections have happened in patients taking ENBREL. These infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some patients have died from these infections. Your healthcare provider should test you for TB before you take ENBREL and monitor you closely for TB before, during, and after ENBREL treatment, even if you have tested negative for TB. There have been some cases of unusual cancers, some resulting in death, reported in children and teenagers who started using tumor necrosis factor (TNF) blockers before 18 years of age. Also, for children, teenagers, and adults taking TNF blockers, including ENBREL, the chances of getting lymphoma or other cancers may increase. Patients with RA may be more likely to get lymphoma. Before starting ENBREL, tell your healthcare provider if you: Have any existing medical conditions Are taking any medicines, including herbals Think you have, are being treated for, have signs of, or are prone to infection. You should not start taking ENBREL if you have any kind of infection, unless your healthcare provider says it is okay Have any open cuts or sores Have diabetes, HIV, or a weak immune system Have TB or have been in close contact with someone who has had TB Were born in, lived in, or traveled to countries where there is more risk for getting TB. Ask your healthcare provider if you are not sure Live, have lived in, or traveled to certain parts of the country (such as, the Ohio and Mississippi River valleys, or the Southwest) where there is a greater risk for certain kinds of fungal infections, such as histoplasmosis. These infections may develop or become more severe if you take ENBREL. If you don’t know if these infections are common in the areas you’ve been to, ask your healthcare provider Have or have had hepatitis B Have or have had heart failure Develop symptoms such as persistent fever, bruising, bleeding, or paleness while taking ENBREL Use the medicine Kineret (anakinra), Orencia (abatacept), or Cytoxan (cyclophosphamide) Are taking anti-diabetic medicines Have, have had, or develop a serious nervous disorder, seizures, any numbness or tingling, or a disease that affects your nervous system such as multiple sclerosis or Guillain-Barré syndrome Are scheduled to have surgery Have recently received or are scheduled for any vaccines. All vaccines should be brought up-to-date before starting ENBREL. Patients taking ENBREL should not receive live vaccines Are pregnant, planning to become pregnant, or breastfeeding Have been around someone with chicken pox What are the possible side effects of ENBREL? ENBREL can cause serious side effects including: New infections or worsening of infections you already have; hepatitis B can become active if you already have had it; nervous system problems, such as multiple sclerosis, seizures, or inflammation of the nerves of the eyes; blood problems (some fatal); new or worsening heart failure; new or worsening psoriasis; allergic reactions; autoimmune reactions, including a lupus-like syndrome and autoimmune hepatitis. Common side effects include: Injection site reactions and upper respiratory infections (sinus infections). In general, side effects in children were similar in frequency and type as those seen in adult patients. The types of infections reported were generally mild and similar to those usually seen in children. These are not all the side effects with ENBREL. Tell your healthcare provider about any side effect that bothers you or does not go away. If you have any questions about this information, be sure to discuss them with your healthcare provider. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Please see Prescribing Information and Medication Guide. [H3] INDICATIONS ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with moderately to severely active rheumatoid arthritis. ENBREL can be taken with methotrexate or used alone. ENBREL is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (pJIA) in children 2 years of age or older. ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in adult patients with psoriatic arthritis. ENBREL can be used with or without methotrexate. ENBREL is indicated for active juvenile psoriatic arthritis (JPsA) in children 2 years of age or older. ENBREL is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis. ENBREL is indicated for chronic moderate to severe plaque psoriasis (PsO) in children 4 years of age or older and adults who may benefit from taking injections or pills (systemic therapy) or phototherapy (ultraviolet light). Open [H5] What is the most important information I should know about ENBREL? ENBREL is a medicine that affects your immune system. ENBREL can lower the ability of your immune system to fight infections.
5484 chars
SUB-PAGE (https://enbrel.com/rheumatoid-arthritis/) Rheumatoid Arthritis Treatment | ENBREL® (etanercept)
Close [H3] [H3] What is the most important information I should know about ENBREL? ENBREL is a medicine that affects your immune system. ENBREL can lower the ability of your immune system to fight infections. Serious infections have happened in patients taking ENBREL. These infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some patients have died from these infections. Your healthcare provider should test you for TB before you take ENBREL and monitor you closely for TB before, during, and after ENBREL treatment, even if you have tested negative for TB. There have been some cases of unusual cancers, some resulting in death, reported in children and teenagers who started using tumor necrosis factor (TNF) blockers before 18 years of age. Also, for children, teenagers, and adults taking TNF blockers, including ENBREL, the chances of getting lymphoma or other cancers may increase. Patients with RA may be more likely to get lymphoma. Before starting ENBREL, tell your healthcare provider if you: Have any existing medical conditions Are taking any medicines, including herbals Think you have, are being treated for, have signs of, or are prone to infection. You should not start taking ENBREL if you have any kind of infection, unless your healthcare provider says it is okay Have any open cuts or sores Have diabetes, HIV, or a weak immune system Have TB or have been in close contact with someone who has had TB Were born in, lived in, or traveled to countries where there is more risk for getting TB. Ask your healthcare provider if you are not sure Live, have lived in, or traveled to certain parts of the country (such as, the Ohio and Mississippi River valleys, or the Southwest) where there is a greater risk for certain kinds of fungal infections, such as histoplasmosis. These infections may develop or become more severe if you take ENBREL. If you don’t know if these infections are common in the areas you’ve been to, ask your healthcare provider Have or have had hepatitis B Have or have had heart failure Develop symptoms such as persistent fever, bruising, bleeding, or paleness while taking ENBREL Use the medicine Kineret (anakinra), Orencia (abatacept), or Cytoxan (cyclophosphamide) Are taking anti-diabetic medicines Have, have had, or develop a serious nervous disorder, seizures, any numbness or tingling, or a disease that affects your nervous system such as multiple sclerosis or Guillain-Barré syndrome Are scheduled to have surgery Have recently received or are scheduled for any vaccines. All vaccines should be brought up-to-date before starting ENBREL. Patients taking ENBREL should not receive live vaccines Are pregnant, planning to become pregnant, or breastfeeding Have been around someone with chicken pox What are the possible side effects of ENBREL? ENBREL can cause serious side effects including: New infections or worsening of infections you already have; hepatitis B can become active if you already have had it; nervous system problems, such as multiple sclerosis, seizures, or inflammation of the nerves of the eyes; blood problems (some fatal); new or worsening heart failure; new or worsening psoriasis; allergic reactions; autoimmune reactions, including a lupus-like syndrome and autoimmune hepatitis. Common side effects include: Injection site reactions and upper respiratory infections (sinus infections). In general, side effects in children were similar in frequency and type as those seen in adult patients. The types of infections reported were generally mild and similar to those usually seen in children. These are not all the side effects with ENBREL. Tell your healthcare provider about any side effect that bothers you or does not go away. If you have any questions about this information, be sure to discuss them with your healthcare provider. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Please see Prescribing Information and Medication Guide. [H3] INDICATIONS ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with moderately to severely active rheumatoid arthritis. ENBREL can be taken with methotrexate or used alone. ENBREL is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (pJIA) in children 2 years of age or older. ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in adult patients with psoriatic arthritis. ENBREL can be used with or without methotrexate. ENBREL is indicated for active juvenile psoriatic arthritis (JPsA) in children 2 years of age or older. ENBREL is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis. ENBREL is indicated for chronic moderate to severe plaque psoriasis (PsO) in children 4 years of age or older and adults who may benefit from taking injections or pills (systemic therapy) or phototherapy (ultraviolet light). Open [H5] What is the most important information I should know about ENBREL? ENBREL is a medicine that affects your immune system. ENBREL can lower the ability of your immune system to fight infections.
5484 chars
SUB-PAGE (https://enbrel.com/psoriatic-arthritis/) Psoriatic Arthritis Treatment | ENBREL® (etanercept)
Close [H3] [H3] What is the most important information I should know about ENBREL? ENBREL is a medicine that affects your immune system. ENBREL can lower the ability of your immune system to fight infections. Serious infections have happened in patients taking ENBREL. These infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some patients have died from these infections. Your healthcare provider should test you for TB before you take ENBREL and monitor you closely for TB before, during, and after ENBREL treatment, even if you have tested negative for TB. There have been some cases of unusual cancers, some resulting in death, reported in children and teenagers who started using tumor necrosis factor (TNF) blockers before 18 years of age. Also, for children, teenagers, and adults taking TNF blockers, including ENBREL, the chances of getting lymphoma or other cancers may increase. Patients with RA may be more likely to get lymphoma. Before starting ENBREL, tell your healthcare provider if you: Have any existing medical conditions Are taking any medicines, including herbals Think you have, are being treated for, have signs of, or are prone to infection. You should not start taking ENBREL if you have any kind of infection, unless your healthcare provider says it is okay Have any open cuts or sores Have diabetes, HIV, or a weak immune system Have TB or have been in close contact with someone who has had TB Were born in, lived in, or traveled to countries where there is more risk for getting TB. Ask your healthcare provider if you are not sure Live, have lived in, or traveled to certain parts of the country (such as, the Ohio and Mississippi River valleys, or the Southwest) where there is a greater risk for certain kinds of fungal infections, such as histoplasmosis. These infections may develop or become more severe if you take ENBREL. If you don’t know if these infections are common in the areas you’ve been to, ask your healthcare provider Have or have had hepatitis B Have or have had heart failure Develop symptoms such as persistent fever, bruising, bleeding, or paleness while taking ENBREL Use the medicine Kineret (anakinra), Orencia (abatacept), or Cytoxan (cyclophosphamide) Are taking anti-diabetic medicines Have, have had, or develop a serious nervous disorder, seizures, any numbness or tingling, or a disease that affects your nervous system such as multiple sclerosis or Guillain-Barré syndrome Are scheduled to have surgery Have recently received or are scheduled for any vaccines. All vaccines should be brought up-to-date before starting ENBREL. Patients taking ENBREL should not receive live vaccines Are pregnant, planning to become pregnant, or breastfeeding Have been around someone with chicken pox What are the possible side effects of ENBREL? ENBREL can cause serious side effects including: New infections or worsening of infections you already have; hepatitis B can become active if you already have had it; nervous system problems, such as multiple sclerosis, seizures, or inflammation of the nerves of the eyes; blood problems (some fatal); new or worsening heart failure; new or worsening psoriasis; allergic reactions; autoimmune reactions, including a lupus-like syndrome and autoimmune hepatitis. Common side effects include: Injection site reactions and upper respiratory infections (sinus infections). In general, side effects in children were similar in frequency and type as those seen in adult patients. The types of infections reported were generally mild and similar to those usually seen in children. These are not all the side effects with ENBREL. Tell your healthcare provider about any side effect that bothers you or does not go away. If you have any questions about this information, be sure to discuss them with your healthcare provider. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Please see Prescribing Information and Medication Guide. [H3] INDICATIONS ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with moderately to severely active rheumatoid arthritis. ENBREL can be taken with methotrexate or used alone. ENBREL is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (pJIA) in children 2 years of age or older. ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in adult patients with psoriatic arthritis. ENBREL can be used with or without methotrexate. ENBREL is indicated for active juvenile psoriatic arthritis (JPsA) in children 2 years of age or older. ENBREL is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis. ENBREL is indicated for chronic moderate to severe plaque psoriasis (PsO) in children 4 years of age or older and adults who may benefit from taking injections or pills (systemic therapy) or phototherapy (ultraviolet light). Open [H5] What is the most important information I should know about ENBREL? ENBREL is a medicine that affects your immune system. ENBREL can lower the ability of your immune system to fight infections.
5484 chars
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
7Review mentions (all pages)
0External proof links (all pages)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 1 | 0 |
| /support/ | 2 | 0 |
| /rheumatoid-arthritis/ | 2 | 0 |
| /psoriatic-arthritis/ | 2 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage — no schema detected (entity gap)
/support/ — no schema detected (entity gap)
/rheumatoid-arthritis/ — no schema detected (entity gap)
/psoriatic-arthritis/ — no schema detected (entity gap)
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Information Density
0 / 30
Read the Narrative & headings: do hard facts (prices, dates, numbers) outweigh fluff power-words?
Semantic Coherence
0 / 20
Compare the homepage promise against the sub-page reality. Do they hold the same line?
Trust & Proof
0 / 20
Weigh review mentions against actual external proof links. Claims without verification = theatre.
Commodity Fingerprint
0 / 15
Check headings & narrative against the industry clichés in the setup above.
Identity & Authority
0 / 15
Inspect the schema: is there real Organization/Person identity with sameAs links, or gaps?
Your predicted BS score
0 / 100
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Information Density
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Semantic Alignment
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Trust & Proof
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Commodity Fingerprint
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Identity & Authority
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS
Based on 784 businesses audited.
BS Detector
Medical Devices, Pharma & Biotech BS: ENBREL (Amgen) (enbrel.com)
https://enbrel.com
📍 Industry: Medical Devices, Pharma & Biotech
33
BS / 100
A rare example of ‘Regulatory Substance’ where legal mandates to disclose side effects inadvertently kill the marketing bullshit. While the technical SEO (Schema) is non-existent, the site provides a clinical level of detail that makes it difficult to dismiss as mere fluff. It is less a marketing site and more a legally-required safety manual with a ‘Simulator’ attachment.
Info Density
Power-words vs. Substance ratio.
9
30% BS
Semantic Coherence
Homepage promise vs. Sub-page reality.
0
0% BS
Trust & Proof
Verifiable evidence vs. Trust Theatre.
8
40% BS
Commodity Fingerprint
Detection of industry clichés/templates.
6
40% BS
Identity & Authority
Expert verifiability & Schema depth.
10
67% BS
Implement comprehensive Drug and Organization JSON-LD schema to bridge the technical authority gap. Replace generic ‘Images are for demonstration purposes only’ in the simulator with a link to the specific peer-reviewed study that validated the simulator’s model. Add direct outbound links to the FDA’s drug approval database for each specific indication. Reduce the BS score by moving the repetitive ISI block into a sticky modal or distinct footer to improve the signal-to-noise ratio of page-specific content.
The site is an exact match for the Pharma and Biotech industry. The content is dominated by regulatory-mandated safety disclosures, clinical indications, and pharmacovigilance instructions, which are hallmarks of a Class III pharmaceutical product site.
“The score of 33 is driven by the total lack of structured data (Identity & Authority) and the extreme repetition of template safety text (Commodity Fingerprint). However, the site avoids a higher score due to its absolute lack of semantic drift and high density of technical medical information required for FDA compliance.”
Verified Analysis Date: May 30, 2026
© 1EuroSEO Independent Evaluator — Non-Sponsored Result
Analysis Disclosure & Source Attribution
This training module utilizes a snapshot of public data from ENBREL (Amgen), captured on May 30, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to ENBREL (Amgen): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://enbrel.com to view the most current version of its content and learn from the source what this company is about and what it offers.